Companies are now growing human brain cells on silicon chips and offering cloud API access for developers to code to them. This bio-compute model, which taught neurons to play a video game in a week, is vastly more energy-efficient than traditional GPU clusters, heralding a new computing paradigm.

Nvidia CEO Jensen Huang predicts that digital biology is on the verge of a massive breakthrough, similar to ChatGPT's impact on AI. He believes that in the next 3-5 years, our ability to represent and understand genes, proteins, and cells will lead to an inflection point for the entire healthcare industry.

A convergence of DNA sequencing, CRISPR, and AI allows scientists to move beyond just understanding biology to actively intervening. Medicine is now programming cellular behavior by rewriting DNA, representing a "step function" leap in what's achievable for treating disease at its root cause.

Jensen Huang forecasts that the next major AI breakthrough will be in digital biology. He believes advances in multimodality, long context models, and synthetic data will converge to create a "ChatGPT moment," enabling the generation of novel proteins and chemicals.

The idea for a living computer came not from biologists, but from engineers with backgrounds in signal processing. This highlights how breakthrough innovations often occur at the intersection of disciplines, where outsiders can reframe a problem from a fresh perspective.

Companies like Cortical Labs are growing human brain cells on chips to create energy-efficient biological computers. This radical approach could power future server farms and make personal 'digital twins' feasible by overcoming the massive energy demands of current supercomputers.

Patrick Collison believes we can finally cure complex diseases because biology now has a complete 'Turing loop': advanced sequencing to 'read' biological data, neural networks to 'think' about it, and CRISPR to 'write' changes by perturbing cells. This combination provides the necessary toolset for breakthroughs.

Bob Nelsen believes the industry overestimates AI's short-term impact and underestimates its long-term potential. He predicts that once a critical data threshold is met, AI models won't just accelerate drug discovery but will fundamentally invent new biology, creating a sudden, paradigm-shifting moment.

Futurist Freeman Dyson predicted biotechnology would follow computing's path, moving from large institutions to individual creators. AI is accelerating this shift by lowering the cognitive barrier to entry, potentially making biological design an accessible, decentralized craft. This counters the dominant narrative of AI as a purely centralizing force.